(Q65539322)

English

Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine

clinical trial

In more languages

Statements

0 references

Subcutaneous Campath-1H in Fludarabine-Refractory CLL (English)

0 references

medical condition

0 references

0 references

0 references

September 2002

0 references

research intervention

fludarabine phosphate

0 references

clinical trial phase

phase II clinical trial

0 references

Krankenhaus Nordwest

0 references

Asklepios Klinik St. Georg

0 references

Hannover Medical School

0 references

Klinikum Oldenburg

0 references

18 year

0 references

65 year

0 references

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q65539322&oldid=1858499634"